Notice of NINDS Policy for Submission of Applications Containing Clinical Trials

Notice Number: NOT-NS-18-054

Key Dates
Release Date: April 3, 2018

Related Announcements
NOT-NS-19-012
NOT-NS-16-034 RESCINDED
NOT-NS-18-011 

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to clarify the policy for submitting investigator-initiated clinical trial applications to NINDS.

Unless otherwise indicated in NIH or NINDS Funding Opportunity Announcements (FOAs), clinical trials designed to answer specific questions about the safety, tolerability, efficacy, effectiveness, clinical management, and/or implementation of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions will only be supported by NINDS if submitted to an NINDS clinical trials-specific FOA.  A current list of active NINDS clinical trials FOAs is available at https://www.ninds.nih.gov/Current-Research/Research-Funded-NINDS/Clinical-Research.  

Applicants are strongly advised to consult with NINDS program staff prior to submitting a clinical trial application to determine the appropriate funding opportunity announcement.

Inquiries

Please direct all inquiries to:

Peter Gilbert, Sc.M.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-0870
Email: GilbertP@ninds.nih.gov